RLS Global AB received its first order of ChloraSolv for clinical use

Report this content

During the autumn of 2019, RLS Global focused on the Swedish market with the aim to get ChloraSolv established as a standard product in the regions. In parallel, RLS has worked in close collaboration with OneMed to penetrate the market in municipalities and regions there OneMed has supplier agreements. RLS Global also has ongoing dialogue with international players in order to establish ChloraSolv in the international market. 

RLS Global has now received the first order of ChloraSolv for clinical use. The size of the order is still of minor nature, but it is an important confirmation that the work carried out during the autumn is now showing result.


‘We believe that during first half of 2020, RLS Global will receive several positive breakthroughs from the Swedish market as a result of the work that took place during autumn 2019 and is according to plan. At the same time, we have just begun the journey towards achieving our ambition that ChloraSolv is the obvious choice in active debridement of chronic wounds. ChloraSolv will also get the first footprints on the international market during 2020, says Karin Fischer – CEO RLS Global’.

Trading place and certified advisor RLS Global’s shares has been listed on the Nasdaq First North since 17th May, 2017 and trading takes place under the short name RLS. Certified Adviser is Erik Penser Bank, telephone +46 8 463 83 00, Email: certifiedadviser@penser.se. During the period 2012 - 2017, the company was listed on Aktietorget.

Contact information
Karin Fischer, CEO
Telephone: +46 702 48 46 51

Anders Husmark, CBDO RLS Global AB
E-mail: anders.husmark@rlsglobal.se
Telephone: +46 724 50 94 03

About RLS Global AB
RLS Global AB is a medical technology company within Life Science. Based on the company's unique hypochlorite platform, RLS  Global develop products for some of our most common illnesses in wound and oral care. RLS Global has a portfolio of strong brands, including ChloraSolv®, Perisolv® and Carisolv®. The company is listed on Nasdaq First North with Erik Penser Bank as Certified Adviser, telephone +46 (0) 8 463 83 00, email: certified adviser@penser.se. Read more at www.rls.global